# User Acceptability of a Nicotine Lactate Delivery System (P3L)

> **NCT02643693** · NA · COMPLETED · sponsor: **Philip Morris Products S.A.** · enrollment: 24 (actual)

## Conditions studied

- Smoking

## Interventions

- **OTHER:** P3L
- **OTHER:** VUSE
- **OTHER:** CC

## Key facts

- **NCT ID:** NCT02643693
- **Lead sponsor:** Philip Morris Products S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11
- **Primary completion:** 2016-05
- **Final completion:** 2016-12
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2019-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02643693

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02643693, "User Acceptability of a Nicotine Lactate Delivery System (P3L)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02643693. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*